Spot Gold Slumped 5%, Recording the Biggest Loss in 7 years

Spot gold price plunged $115.00 or 5.70% to $1,911 an ounce yesterday, the biggest daily dollar slide in over seven years, as investors turned optimistic that a coronavirus vaccine would come soon.

Gold 1

Spot gold price plunged $115.00 or 5.70% to $1,911 an ounce yesterday, the biggest daily dollar slide in over seven years, as investors turned optimistic that a coronavirus vaccine would come soon.

Russian President Vladimir Putin said the world's first Covid-19 vaccine are ready to use, even before clinical testing has finished.

Besides, U.S. President Donald Trump said he is seriously considering a capital gains tax cut, which also increases the investors risk appetite.

Spot Gold (Short Term): Turning Down


Source: GAIN Capital, Tradingview

Technically, the spot gold prices sharply retreated with a long range bearish candlestick on a daily chart. Currently, the prices broke below the 20-day moving average.

The relative strength index dramatically fell from the overbought level and also broke below the rising trend line drawn from March. 

Bearish readers could place the nearest resistance level at $2,015, while support levels would be located at $1,770 and $1,715.


Spot Gold (Intraday): Further decline expected


Source: GAIN Capital, TradingView

On a 1-hour chart, Spot gold has recorded a series of lower tops and lower bottoms since August 7, indicating a bearish outlook.

The relative strength index is capped by a declining trend line drawn from August 5, suggesting the downside momentum for the prices.

In this case, as long as the resistance level at $1,930 (the previous high) is not surpassed, gold prices could consider a further downside to the support levels at $1,845 and $1,820.


More from Gold

From time to time, GAIN Capital Australia Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.

As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.